Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 2/20 | 0.50 |
| ▸ | ADH1C | P00326 | 2/20 | 0.50 |
| ▸ | ADH1A | P07327 | 2/20 | 0.50 |
| ▸ | ADH7 | P40394 | 2/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.50 |
| ▸ | ADH4 | P08319 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 2/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.38 |
| ▸ | PPARA | Q07869 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10574949 | 1.00 | ADH1B (0.50) | ADH1BADH1CADH1AADH7EPHX1 | |
| SCHEMBL1485868 | 0.93 | ADH1B (0.48) | ADH1BADH1CADH1AADH7EPHX1 | |
| SCHEMBL1485866 | 0.93 | ADH1B (0.48) | ADH1BADH1CADH1AADH7EPHX1 | |
| SCHEMBL28188045 | 0.91 | ADH1B (0.50) | ADH1BADH1CADH1AADH7EPHX1 | |
| SCHEMBL29291022 | 0.88 | ADH1B (0.54) | ADH1BADH1CADH1AADH7EPHX1 | |
| SCHEMBL28375811 | 0.88 | ADH1B (0.54) | ADH1BADH1CADH1AADH7EPHX1 | |
| SCHEMBL14661550 | 0.88 | ADH1B (0.54) | ADH1BADH1CADH1AADH7EPHX1 | |
| SCHEMBL22798926 | 0.88 | ADH1B (0.54) | ADH1BADH1CADH1AADH7EPHX1 | |
| SCHEMBL8631417 | 0.88 | ADH1B (0.54) | ADH1BADH1CADH1AADH7EPHX1 | |
| SCHEMBL7756930 | 0.85 | ADH1B (0.45) | ADH1BADH1CADH1AADH7EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10857530-B2 | Olefin metathesis catalysts | UMICORE AG & CO. KG (DE) | 2020-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10857530-B2 | Olefin metathesis catalysts | ZDHHC7, ZDHHC2, OSBP | ADH1B 1700/4885ADH1C 1966/4885ADH1A 1390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.